J. Helmijr

IGF1R signaling drives antiestrogen resistance through PAK2/PIX activation in luminal breast cancer

M. Look, E. Berns, Jean C. A. Helmijr, 2018, Oncogene.

Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes

James D. Brenton, Muhammed Murtaza, Anna M. Piskorz, 2014, PloS one.

Plasma ESR1 mutations and outcome to first-line paclitaxel and bevacizumab in patients with advanced ER-positive/HER2-negative breast cancer

S. Sleijfer, A. Jager, M. Jansen, 2023, Breast Cancer Research and Treatment.

miRNA expression profiling of 51 human breast cancer cell lines reveals subtype and driver mutation-specific miRNAs

J. Foekens, M. Riaz, Marijn T. M. van Jaarsveld, 2013, Breast Cancer Research.

Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer

S. Sleijfer, A. Sieuwerts, Jean C. A. Helmijr, 2020, BMC cancer.

Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer

M. Jansen, S. Lagarde, M. Doukas, 2022, The Journal of pathology.

Machine learning-based somatic variant calling in cell-free DNA of metastatic breast cancer patients using large NGS panels

A. Jager, M. Jansen, R. van Marion, 2023, Scientific reports.

Increased MAPK1/3 Phosphorylation in Luminal Breast Cancer Related with PIK3CA Hotspot Mutations and Prognosis

E. Berns, Jean C. A. Helmijr, J. Martens, 2017, Translational oncology.